UDICARE 600 SR

MRP

MRP 780/Strip

Description

• Each uncoated sustained release tablet contains Ursodeoxycholic Acid IP 600 mg

Doses

• As Directed by physician

Indication

• Ursodeoxycholic acid is indicated in the treatment of primary biliary cirrhosis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder. Hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years.